You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Harvard Business School
Dow
McKinsey
Johnson and Johnson

Last Updated: January 21, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for PIM-35

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug PIM-35?

PIM-35 is an investigational drug.

There have been 7 clinical trials for PIM-35. The most recent clinical trial was a Phase 1 trial, which was initiated on October 1st 2015.

The most common disease conditions in clinical trials are Multiple Myeloma, Undifferentiated Connective Tissue Diseases, and Myelodysplastic-Myeloproliferative Diseases. The leading clinical trial sponsors are Astex Pharmaceuticals, Incyte Corporation, and Michael Savona.

There is one US patent protecting this investigational drug and eighteen international patents.

Recent Clinical Trials for PIM-35
TitleSponsorPhase
INCB053914 (Pan-PIM Kinase Inhibitor) and Pomalidomide With Dexamethasone in Patients With Relapsed and/or Refractory Multiple MyelomaMedical College of WisconsinPhase 1
A Basket Study of Novel Therapy for Untreated MDS/MPN and Relapsed/Refractory Overlap Syndromes (ABNL-MARRO)Astex PharmaceuticalsPhase 1/Phase 2
A Basket Study of Novel Therapy for Untreated MDS/MPN and Relapsed/Refractory Overlap Syndromes (ABNL-MARRO)Incyte CorporationPhase 1/Phase 2

See all PIM-35 clinical trials

Clinical Trial Summary for PIM-35

Top disease conditions for PIM-35
Top clinical trial sponsors for PIM-35

See all PIM-35 clinical trials

International Patents for PIM-35

Drugname Country Document Number Estimated Expiration Related US Patent
PIM-35 Austria AT85047 2009-02-08   Start Trial
PIM-35 Australia AU5029990 2009-02-08   Start Trial
PIM-35 Australia AU626640 2009-02-08   Start Trial
PIM-35 Canada CA2025663 2009-02-08   Start Trial
PIM-35 Germany DE69000806 2009-02-08   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Harvard Business School
Dow
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.